Share

April 19, 2011; 76 (16) Articles

A phase II trial of huperzine A in mild to moderate Alzheimer disease

M.S. Rafii, S. Walsh, J.T. Little, K. Behan, B. Reynolds, C. Ward, S. Jin, R. Thomas, P.S. Aisen, For the Alzheimer's Disease Cooperative Study
First published April 18, 2011, DOI: https://doi.org/10.1212/WNL.0b013e318216eb7b
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1326

Share

Article Information

vol. 76 no. 16 1389-1394
DOI: 
https://doi.org/10.1212/WNL.0b013e318216eb7b
PubMed: 
21502597
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received May 12, 2010
  • Accepted January 10, 2011
  • First Published April 18, 2011.
Copyright & Usage: 
Copyright © 2011 by AAN Enterprises, Inc.

Author Disclosures

    1. M.S. Rafii, MD, PhD,
    2. S. Walsh, MD,
    3. J.T. Little, MD,
    4. K. Behan,
    5. B. Reynolds, NP,
    6. C. Ward,
    7. S. Jin, MD,
    8. R. Thomas, PhD,
    9. P.S. Aisen, MD and
    10. For the Alzheimer's Disease Cooperative Study
  1. M.S. Rafii, MD, PhD,
  2. S. Walsh, MD,
  3. J.T. Little, MD,
  4. K. Behan,
  5. B. Reynolds, NP,
  6. C. Ward,
  7. S. Jin, MD,
  8. R. Thomas, PhD,
  9. P.S. Aisen, MD and
  10. For the Alzheimer's Disease Cooperative Study
  1. From the Department of Neurosciences (M.S.R., S.J., R.T., P.S.A.), School of Medicine, University of California, San Diego, La Jolla; and Department of Neurology (S.W., J.T.T., K.B., B.R., C.W.), School of Medicine, Georgetown University, Washington, DC.
  1. Address correspondence and reprint requests to Dr. Michael S. Rafii, 9500 Gilman Drive #0949, La Jolla, CA 92093 mrafii{at}ucsd.edu

Article usage

Article usage: April 2011 to October 2023

AbstractFullPdfSource
Apr 201113095297Highwire
May 20114042941Highwire
Jun 20112202925Highwire
Jul 20111552426Highwire
Aug 20111002013Highwire
Sep 201151149Highwire
Oct 20116859Highwire
Nov 201194310Highwire
Dec 20116742Highwire
Jan 20129029Highwire
Feb 201279911Highwire
Mar 20129567Highwire
Apr 20126211Highwire
May 201210179Highwire
Jun 20127421Highwire
Jul 20126452Highwire
Aug 20122734Highwire
Sep 20123137Highwire
Oct 20123034Highwire
Nov 20123545Highwire
Dec 20122323Highwire
Jan 20136365Highwire
Feb 20135532Highwire
Mar 20135642Highwire
Apr 20135171Highwire
May 20137311Highwire
Jun 20132810Highwire
Jul 20133210Highwire
Aug 20132300Highwire
Sep 20132412Highwire
Oct 20133221Highwire
Nov 20135211Highwire
Dec 20133811Highwire
Jan 20143811Highwire
Jan 201404621pmc
Feb 20144400Highwire
Mar 20144121Highwire
Apr 20145400Highwire
May 20142200Highwire
Jun 20141831Highwire
Jul 20143135Highwire
Aug 20142422Highwire
Sep 20143500Highwire
Oct 20144032Highwire
Nov 20142200Highwire
Dec 20142820Highwire
Jan 20155910Highwire
Jan 201507126pmc
Feb 20153032Highwire
Feb 201505413pmc
Mar 20153100Highwire
Mar 201505224pmc
Apr 20153731Highwire
Apr 201505922pmc
May 20153611Highwire
May 201505427pmc
Jun 20153034Highwire
Jun 201505725pmc
Jul 20156612Highwire
Jul 201503810pmc
Aug 20153612Highwire
Aug 201504316pmc
Sep 20154110Highwire
Sep 201502919pmc
Oct 20151931Highwire
Oct 20150325pmc
Nov 20152601Highwire
Nov 201506226pmc
Dec 20154112Highwire
Dec 201505224pmc
Jan 20165920Highwire
Jan 201604324pmc
Feb 20163430Highwire
Feb 201607013pmc
Mar 20162441Highwire
Mar 20160429pmc
Apr 20162100Highwire
Apr 201604616pmc
May 20162300Highwire
May 201605315pmc
Jun 20162600Highwire
Jun 201603012pmc
Jul 20163031Highwire
Jul 20160235pmc
Aug 20163825Highwire
Aug 201603418pmc
Sep 20162600Highwire
Sep 201604215pmc
Oct 20163400Highwire
Oct 20160457pmc
Nov 20162702Highwire
Nov 20160268pmc
Dec 20162610Highwire
Dec 20160358pmc
Jan 20173010Highwire
Jan 201704215pmc
Feb 20172801Highwire
Feb 20170399pmc
Mar 20173200Highwire
Mar 201703010pmc
Apr 20173011Highwire
Apr 2017134148pmc
May 20172100Highwire
May 201793234pmc
Jun 20172101Highwire
Jun 201782931pmc
Jul 20171310Highwire
Jul 201773433pmc
Aug 20172000Highwire
Aug 201742725pmc
Sep 20171800Highwire
Sep 201783239pmc
Oct 20172500Highwire
Oct 2017143740pmc
Nov 20171300Highwire
Nov 2017134874pmc
Dec 20173601Highwire
Jan 20184701Highwire
Feb 20183741Highwire
Mar 20182010Highwire
Apr 20181851Highwire
Apr 2018124356pmc
May 20183901Highwire
Jun 20182800Highwire
Jun 201853341pmc
Jul 20182110Highwire
Aug 20183110Highwire
Aug 201834058pmc
Sep 20181801Highwire
Oct 20183011Highwire
Nov 20183200Highwire
Dec 20185300Highwire
Jan 20192522Highwire
Feb 20192201Highwire
Mar 20193412Highwire
Apr 20194302Highwire
May 20199611Highwire
Jun 20192200Highwire
Jul 20194512Highwire
Aug 20193300Highwire
Sep 20195203Highwire
Oct 20193200Highwire
Nov 20195311Highwire
Dec 20192300Highwire
Jan 20201800Highwire
Feb 20202700Highwire
Mar 20204903Highwire
Apr 20203000Highwire
May 20203210Highwire
Jun 20202211Highwire
Jul 20203100Highwire
Aug 20203311Highwire
Sep 20201500Highwire
Oct 20207000Highwire
Nov 20203710Highwire
Dec 20204101Highwire
Jan 20215200Highwire
Feb 20214601Highwire
Mar 20214110Highwire
Apr 20217011Highwire
May 20215100Highwire
Jun 20216022Highwire
Jul 20218711Highwire
Aug 202110300Highwire
Sep 20218300Highwire
Oct 20219822Highwire
Nov 20217522Highwire
Dec 20216400Highwire
Jan 20225600Highwire
Feb 20227700Highwire
Mar 20229800Highwire
Apr 20227800Highwire
May 202212605Highwire
Jun 20224822Highwire
Jul 20223845Highwire
Aug 20225101Highwire
Sep 20224120Highwire
Oct 20224901Highwire
Nov 20226710Highwire
Dec 20228900Highwire
Jan 20239200Highwire
Feb 20237001Highwire
Mar 20236711Highwire
Apr 20237511Highwire
May 20238300Highwire
Jun 20237600Highwire
Jul 20239001Highwire
Aug 20238200Highwire
Sep 20239200Highwire
Oct 20238200Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles